Corvus Pharmaceuticals, Inc. — Form D
Corvus Pharmaceuticals, Inc. of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-25. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2015-09-25
- Form: D
- Accession: 0001626971-15-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $75.0M
- Amount sold: $75.0M
- Investors: 33
- Date of first sale: 2015-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-248244
Issuer
- Name: Corvus Pharmaceuticals, Inc.
- CIK: 0001626971
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 863 MITTEN ROAD, BURLINGAME, CA, 94010
- Phone: (650) 900-4520
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Elisha (Terry) P Gould | Director | Chicago, IL |
| RICHARD A MILLER | Director | BOCA RATON, FL |
| Peter P Moldt | Director | Kellenup, G7 |
| Peter P Thompson | Director | New York, NY |
| Leiv P Lea | Executive Officer | Burlingame, CA |
| RICHARD A MILLER | Executive Officer | BOCA RATON, FL |
| Terry G Gould | Director | Chicago, IL |
| Leiv G Lea | Executive Officer | Portola Valley, CA |
| Peter G Thompson | Director | New York, NY |
Other filings by this issuer (1)
More